These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33310117)

  • 41. [Epidemiological surveillance of Bordetella pertussis and parapertussis sensitivity to antibiotics].
    Janovská D; Výmola F
    Cesk Epidemiol Mikrobiol Imunol; 1971 Jul; 20(4):184-8. PubMed ID: 4328643
    [No Abstract]   [Full Text] [Related]  

  • 42. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis.
    Brett M; Short P; Beatson S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():23-7. PubMed ID: 9579709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.
    Fry NK; Duncan J; Vaghji L; George RC; Harrison TG
    Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1183-5. PubMed ID: 20521155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
    Wilson KE; Cassiday PK; Popovic T; Sanden GN
    J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.
    Hoppe JE; Paulus T
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):391-3. PubMed ID: 9758277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.
    Lebel MH; Mehra S
    Pediatr Infect Dis J; 2001 Dec; 20(12):1149-54. PubMed ID: 11740322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azithromycin Clears
    Borkner L; Misiak A; Wilk MM; Mills KHG
    Front Immunol; 2018; 9():1764. PubMed ID: 30105030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibility of Bordetella pertussis (Part I).
    Hoppe JE; Haug A
    Infection; 1988; 16(2):126-30. PubMed ID: 2897337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pertussis (Whooping cough)--an update].
    Stock I
    Med Monatsschr Pharm; 2015 Dec; 38(12):484-8. PubMed ID: 26837155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008-2012.
    Horiba K; Nishimura N; Gotoh K; Kawaguchi M; Takeuchi S; Hattori F; Isaji M; Okai Y; Hosono H; Takemoto K; Ozaki T
    Jpn J Infect Dis; 2014; 67(5):345-8. PubMed ID: 25241683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comprehensive resource for Bordetella genomic epidemiology and biodiversity studies.
    Bridel S; Bouchez V; Brancotte B; Hauck S; Armatys N; Landier A; Mühle E; Guillot S; Toubiana J; Maiden MCJ; Jolley KA; Brisse S
    Nat Commun; 2022 Jul; 13(1):3807. PubMed ID: 35778384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevention and treatment of pertussis.
    Chaudhry R; Nagpaul-Chaudhry I; Buchta WG; Kircher KJ; Sampathkumar P
    Manag Care Interface; 2007 Feb; 20(2):43-6. PubMed ID: 17405582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Fusco J; Biedenbach DJ; Pfaller MA; Jones RN
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3599-600. PubMed ID: 11709347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Need for equivalence testing of efficacy of alternative antibiotics for treatment of pertussis.
    Baughman AL; Bisgard KM
    Pediatr Infect Dis J; 2003 Feb; 22(2):205-7. PubMed ID: 12586986
    [No Abstract]   [Full Text] [Related]  

  • 55. [Action to be taken when facing one or more cases of whooping-cough].
    Floret D; Bonmarin I; Deutsch P; Gaudelus J; Grimprel E; Guérin N; Guiso N; Morer I
    Arch Pediatr; 2005 Aug; 12(8):1281-91. PubMed ID: 15961299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro sensitivity of Bordetella pertussis.
    Zackrisson G; Brorson JE; Krantz I; Trollfors B
    J Antimicrob Chemother; 1983 May; 11(5):407-11. PubMed ID: 6307963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pertussis: The Whooping Cough.
    Nguyen VTN; Simon L
    Prim Care; 2018 Sep; 45(3):423-431. PubMed ID: 30115332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington.
    Galanakis E; Englund JA; Abe P; Qin X
    Int J Antimicrob Agents; 2007 May; 29(5):609-11. PubMed ID: 17344029
    [No Abstract]   [Full Text] [Related]  

  • 59. Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.
    Koide K; Yao S; Chiang CS; Thuy PTB; Nga DTT; Huong DT; Dien TM; Vichit O; Vutthikol Y; Sovannara S; Samnang C; Takayama I; Ainai A; Nakajima N; Otsuka N; Kamachi K; Saitoh A
    J Glob Antimicrob Resist; 2022 Dec; 31():263-269. PubMed ID: 36270447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Letter: The role of antimicrobial agents in the treatment of pertussis.
    Bass JW
    J Pediatr; 1973 Nov; 83(5):891-3. PubMed ID: 4355098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.